Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a Digital Tool That Uses National Testing Guidelines to Identify Individuals at Risk for Hereditary Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.

Annals of internal medicine·2022
Same author

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2022
Same author

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer.

NPJ genomic medicine·2022
Same author

Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond <i>BRCA1</i> and <i>BRCA2</i> in Breast and Ovarian Cancer Patients.

Cancers·2022
Same author

<i>PTEN</i> Promoter Variants Are Not Associated With Common Cancers: Implications for Multigene Panel Testing.

JCO precision oncology·2022

Related Experiment Video

Updated: Jan 5, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Current prostate cancer genetic testing capabilities and considerations.

Robert Pilarski1

  • 1Division of Human Genetics, James Comprehensive Cancer Center, Columbus, Ohio, USA.

The Canadian Journal of Urology
|October 21, 2019
PubMed
Summary
This summary is machine-generated.

Genetic testing for prostate cancer now uses multi-gene panels, ranging from targeted to comprehensive options. Choosing the right panel and lab, alongside direct-to-consumer tests, presents key considerations for patients.

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.1K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.4K

Related Experiment Videos

Last Updated: Jan 5, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.1K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.4K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Diagnostics

Background:

  • Next-generation sequencing enables comprehensive genetic testing for prostate cancer.
  • Multi-gene panels are now standard for genetic analysis in prostate cancer patients.

Purpose of the Study:

  • To review issues in selecting appropriate genetic testing panels for prostate cancer.
  • To discuss the selection of reliable laboratories for genetic analysis.
  • To address challenges posed by direct-to-consumer genetic testing options.

Main Methods:

  • Literature review of current practices in prostate cancer genetic testing.
  • Analysis of advantages and disadvantages of different multi-gene panel types (targeted vs. comprehensive).
  • Examination of factors influencing laboratory selection for genetic testing.

Main Results:

  • Multi-gene panels offer diverse approaches, each with specific benefits and drawbacks.
  • The choice between targeted and comprehensive panels depends on clinical context.
  • Direct-to-consumer testing introduces new considerations for patient genetic information.

Conclusions:

  • Informed selection of genetic testing panels and laboratories is crucial for prostate cancer management.
  • Understanding the nuances of different panel types is essential for optimal patient care.
  • The evolving landscape of genetic testing, including direct-to-consumer options, requires careful evaluation.